Abstract
PPM1D is a p53-inducible Ser/Thr protein phosphatase. PPM1D gene amplification and overexpression have been reported in a variety of human tumors, including breast cancer and neuroblastoma. Because the phosphatase activity of PPM1D is essential for its oncogenic role, PPM1D inhibitors should be viable anti-cancer agents. In our current study, we showed that SPI-001 was a potent and specific PPM1D inhibitor. SPI-001 inhibited PPM1D phosphatase activity in PPM1D-overexpressing human breast cancer cells and increased phosphorylation of p53. Furthermore, SPI-001 suppressed cell proliferation by inducing apoptosis. Our present study suggested that SPI-001 was a potential lead compound in developing anti-cancer drugs.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / pharmacology
-
Apoptosis
-
Ataxia Telangiectasia Mutated Proteins
-
Cell Cycle Proteins / metabolism
-
Cell Line, Tumor
-
Cell Proliferation
-
DNA-Binding Proteins / metabolism
-
Dose-Response Relationship, Drug
-
Humans
-
Indoles / pharmacology
-
Inhibitory Concentration 50
-
Models, Chemical
-
Neoplasms / drug therapy*
-
Phenanthrenes / pharmacology*
-
Phosphoprotein Phosphatases / antagonists & inhibitors*
-
Phosphoric Monoester Hydrolases / chemistry
-
Phosphorylation
-
Protein Phosphatase 2C
-
Protein Serine-Threonine Kinases / metabolism
-
Proto-Oncogene Proteins pp60(c-src) / metabolism
-
Time Factors
-
Tumor Suppressor Protein p53 / metabolism*
-
Tumor Suppressor Proteins / metabolism
Substances
-
Antineoplastic Agents
-
Cell Cycle Proteins
-
DNA-Binding Proteins
-
Indoles
-
Phenanthrenes
-
SPI-001
-
Tumor Suppressor Protein p53
-
Tumor Suppressor Proteins
-
DAPI
-
MATK protein, human
-
Proto-Oncogene Proteins pp60(c-src)
-
ATM protein, human
-
Ataxia Telangiectasia Mutated Proteins
-
Protein Serine-Threonine Kinases
-
PPM1D protein, human
-
Phosphoprotein Phosphatases
-
Protein Phosphatase 2C
-
Phosphoric Monoester Hydrolases